Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the ...

Novo Nordisk (NVO) stock pares losses as the company plans Ozempic pill launch in Q2 2026 after FDA OKs the name for several ...

The MarketWatch News Department was not involved in the creation of this content.-- Novo Nordisk's first big game spot introduces America to the FDA-approved Wegovy(R) pill -- the ...

Honored “for incredible work using technology to combat social isolation,” this marks ONSCREEN’s third CES award in ...

A Novo executive noted that many customers are unaware that the company already makes oral semaglutide for type 2 diabetes ...

Activity Connection and Zinnia TV today announced a strategic partnership to integrate structured life enrichment programming ...

Discover the best tablets for seniors in 2026, featuring the top pick Apple iPad (10th Generation) for its excellent ...

More batches of baby formula have been recalled over toxin fears. Elsewhere, it's been announced the TV licence fee will go ...

The proposal would restrict sales to adults, ban candy-like products and remove concentrated 7-hydroxymitragynine from the ...

DENVER, CO / / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous ...

Finland issues new national digital guidelines for children, advising against smartphones and social media for under-13s and setting strict limits on screen time in early childhood.

Don't have nightmares, but some horrible creatures come out on to your face at night - and doctors can't agree whether they ...